Effect of Empagliflozin on Body Composition and Ketones

Clinical trial NCT03877406 · UNKNOWN

Trial details

NCT number: NCT03877406
Sponsor: Seoul National University Bundang Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus Fat; Intolerance, Pancreas

Start date: 2018-08-01
Primary completion: 2023-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.